A small scale observational study published in the Journal of the Israeli Medical Association looked at the effects of cannabis usage among patients who had Crohn’s Disease.
The study found 30 patients through an Israeli medical marijuana organization. They asked these patients about their disease & wellbeing before & after cannabis usage. When possible, they referenced the answers given with the patients medical records. Most all of the patients had been on conventional treatments such as anti-inflammatories, corticosteriods & some where also using anti-tumor necrosis factor antibodies. About half had also experienced the need to have surgery at some point. These patients opted to use marijuana due to the fact that they were not responding well to conventional treatments. The average amount of THC(tetrahydrocannabinol) intake from marijuana per day was about 0.5mg – 1.5mg. Continue reading “Study Suggests Cannabis Helpful In Treating Inflammatory Bowel Disease” »
A recent study published in Gastroenterology(Vol. 140, Issue 5) has found that Dronabinol may help with treating Irritable Bowel Syndrome symptoms. Dronabinol is a purified form of THC which is the active ingredient of cannabis(Marijuana).
Patients were split into two groups, one group was given 2.5mg of Dronabinol while the other group was given 5mg. Tests were done to measure colon motility & compliance 1 hour after taking the oral treatment & 1 hour after eating a 1,000 calorie meal. Continue reading “Study Supports Marijuana’s THC Helpful For IBS” »
Oregon senator Robert Kruse is sponsoring Oregon Senate Bill 777 which aims to reduce the number of ailments medical marijuana can be used for as well creating stricter criteria regarding it’s use with ailments that would remain allowable. Additionally it would require patients to have a doctor verify their illness & eligibility every six months. Continue reading “Oregon Bill Threatens To Restrict Patient Access To Medical Marijuana” »